Last reviewed · How we verify
Simultaneous Therapy With Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edema
Retrospective cases series is a non-randomized, open-label, single-center investigation (Retina Clinic, São Paulo, Brazil) of patients diagnosed with macular edema secondary to diabetic retinopathy (DME) and retinal vein occlusions who underwent to simultaneous treatment with intravitreal injection of bevacizumab 1.25mg and implant of dexamethasone 0.7mg.
Details
| Lead sponsor | Retina Clinic, Sao Paulo, Brazil |
|---|---|
| Status | COMPLETED |
| Enrolment | 20 |
| Start date | 2015-09 |
| Completion | 2016-02 |
Conditions
- Macular Edema
Interventions
- simultaneous treatment with intravitreal injection of bevacizumab 1.25mg and intravitreal implant of dexamethasone 0.7mg.
Primary outcomes
- Improvement in BCVA — 6 months
Countries
Brazil